rs754481229

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 8P and 10B. PVS1BP6_ModerateBS1BS2

The NM_001388492.1(HTT):​c.102_105delGCAG​(p.Gln34HisfsTer66) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0161 in 141,172 control chromosomes in the GnomAD database, including 36 homozygotes. Variant has been reported in ClinVar as Benign (★). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.016 ( 36 hom., cov: 25)
Exomes 𝑓: 0.011 ( 249 hom. )
Failed GnomAD Quality Control

Consequence

HTT
NM_001388492.1 frameshift

Scores

Not classified

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 1.80

Publications

1 publications found
Variant links:
Genes affected
HTT (HGNC:4851): (huntingtin) Huntingtin is a disease gene linked to Huntington's disease, a neurodegenerative disorder characterized by loss of striatal neurons. This is thought to be caused by an expanded, unstable trinucleotide repeat in the huntingtin gene, which translates as a polyglutamine repeat in the protein product. A fairly broad range of trinucleotide repeats (9-35) has been identified in normal controls, and repeat numbers in excess of 40 have been described as pathological. The huntingtin locus is large, spanning 180 kb and consisting of 67 exons. The huntingtin gene is widely expressed and is required for normal development. It is expressed as 2 alternatively polyadenylated forms displaying different relative abundance in various fetal and adult tissues. The larger transcript is approximately 13.7 kb and is expressed predominantly in adult and fetal brain whereas the smaller transcript of approximately 10.3 kb is more widely expressed. The genetic defect leading to Huntington's disease may not necessarily eliminate transcription, but may confer a new property on the mRNA or alter the function of the protein. One candidate is the huntingtin-associated protein-1, highly expressed in brain, which has increased affinity for huntingtin protein with expanded polyglutamine repeats. This gene contains an upstream open reading frame in the 5' UTR that inhibits expression of the huntingtin gene product through translational repression. [provided by RefSeq, Jul 2016]
HTT Gene-Disease associations (from GenCC):
  • Huntington disease
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
  • Lopes-Maciel-Rodan syndrome
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • juvenile Huntington disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
BP6
Variant 4-3074926-AGCAG-A is Benign according to our data. Variant chr4-3074926-AGCAG-A is described in ClinVar as [Benign]. Clinvar id is 402953.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0161 (2277/141172) while in subpopulation NFE AF = 0.0237 (1528/64438). AF 95% confidence interval is 0.0227. There are 36 homozygotes in GnomAd4. There are 1027 alleles in the male GnomAd4 subpopulation. Median coverage is 25. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 36 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HTTNM_001388492.1 linkc.102_105delGCAG p.Gln34HisfsTer66 frameshift_variant Exon 1 of 67 ENST00000355072.11 NP_001375421.1
HTTNM_002111.8 linkc.102_105delGCAG p.Gln34HisfsTer66 frameshift_variant Exon 1 of 67 NP_002102.4 P42858

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HTTENST00000355072.11 linkc.102_105delGCAG p.Gln34HisfsTer66 frameshift_variant Exon 1 of 67 1 NM_001388492.1 ENSP00000347184.5 P42858

Frequencies

GnomAD3 genomes
AF:
0.0162
AC:
2281
AN:
141102
Hom.:
36
Cov.:
25
show subpopulations
Gnomad AFR
AF:
0.00520
Gnomad AMI
AF:
0.0108
Gnomad AMR
AF:
0.0131
Gnomad ASJ
AF:
0.0631
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0108
Gnomad FIN
AF:
0.00518
Gnomad MID
AF:
0.0362
Gnomad NFE
AF:
0.0237
Gnomad OTH
AF:
0.0215
GnomAD2 exomes
AF:
0.00741
AC:
728
AN:
98246
AF XY:
0.00762
show subpopulations
Gnomad AFR exome
AF:
0.00233
Gnomad AMR exome
AF:
0.00402
Gnomad ASJ exome
AF:
0.0230
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00305
Gnomad NFE exome
AF:
0.00883
Gnomad OTH exome
AF:
0.00997
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0113
AC:
15025
AN:
1325628
Hom.:
249
AF XY:
0.0115
AC XY:
7510
AN XY:
653424
show subpopulations
African (AFR)
AF:
0.00323
AC:
87
AN:
26944
American (AMR)
AF:
0.00590
AC:
194
AN:
32870
Ashkenazi Jewish (ASJ)
AF:
0.0370
AC:
870
AN:
23540
East Asian (EAS)
AF:
0.00
AC:
0
AN:
31344
South Asian (SAS)
AF:
0.00624
AC:
466
AN:
74672
European-Finnish (FIN)
AF:
0.00720
AC:
245
AN:
34050
Middle Eastern (MID)
AF:
0.0284
AC:
114
AN:
4014
European-Non Finnish (NFE)
AF:
0.0118
AC:
12315
AN:
1043258
Other (OTH)
AF:
0.0134
AC:
734
AN:
54936
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
592
1184
1777
2369
2961
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
384
768
1152
1536
1920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0161
AC:
2277
AN:
141172
Hom.:
36
Cov.:
25
AF XY:
0.0149
AC XY:
1027
AN XY:
68954
show subpopulations
African (AFR)
AF:
0.00521
AC:
193
AN:
37028
American (AMR)
AF:
0.0131
AC:
190
AN:
14526
Ashkenazi Jewish (ASJ)
AF:
0.0631
AC:
209
AN:
3310
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4824
South Asian (SAS)
AF:
0.0104
AC:
47
AN:
4516
European-Finnish (FIN)
AF:
0.00518
AC:
49
AN:
9452
Middle Eastern (MID)
AF:
0.0355
AC:
10
AN:
282
European-Non Finnish (NFE)
AF:
0.0237
AC:
1528
AN:
64438
Other (OTH)
AF:
0.0214
AC:
42
AN:
1960
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
105
210
314
419
524
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: To date, only repeat expansions in this gene are known to be implicated in disease -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.8
Mutation Taster
=187/13
disease causing (fs/PTC)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs754481229; hg19: chr4-3076653; API